Inhaled nitric oxide
Active Awarded Last action
- Contract number
- W81K0026FA029
- Awardee
-
INO Therapeutics LLC UEI XXQHL619FUN6
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $158,312
Award facts
- Contract value 100% obligated
- $158,312.00 Current and potential, with all options
- Completion date 80% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- JBSA FT SAM HOUSTON, TX 78234, USA
Award details come from SAM.gov/FPDS.
About this award
INO Therapeutics LLC, a Missouri-based supplier of specialized medical gases and respiratory therapy systems, was awarded a delivery order contract valued at $158,312 by the Defense Health Agency effective January 1, 2026, with completion targeted for December 31, 2026. This firm fixed-price delivery order procures inhaled nitric oxide (INOMAX) therapeutic gas and related inhalation therapy services for delivery to JBSA Fort Sam Houston in San Antonio, Texas. The contract carries no small business set-aside designation and operates as a child contract under the Defense Health Agency's Blanket Purchase Agreement established on March 20, 2025, with a $404,200 ceiling value through March 19, 2030, issued under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB).
INO Therapeutics has established itself as a critical federal contractor providing nitric oxide therapeutic gases and respiratory care equipment to the Department of Veterans Affairs across multiple Veterans Integrated Service Networks, the Defense Health Agency, and other federal healthcare facilities including the National Institutes of Health and the Army Medical Command. The company maintains three active blanket purchase agreements supporting indefinite delivery/indefinite quantity procurement of specialized medical gases and inhalation therapy services. With extensive experience delivering inhaled nitric oxide supplies to neonatal, pediatric, and adult critical care populations across the federal healthcare system, INO Therapeutics provides comprehensive respiratory therapy support to veterans, active service members, and military beneficiaries requiring advanced therapeutic gas interventions.
Quick answers
Who was awarded contract W81K0026FA029?
W81K0026FA029 was awarded to INO Therapeutics LLC by Medical Command (Department of the Army) on January 1, 2026.
How much is contract W81K0026FA029 worth?
The government has obligated $158,312 on W81K0026FA029.
Which agency awarded contract W81K0026FA029?
Medical Command (Department of the Army) awarded W81K0026FA029, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0026FA029 an order under another contract?
Yes. W81K0026FA029 is a delivery order under V797D60737, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract W81K0026FA029 competed?
The extent of competition for W81K0026FA029 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award